These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2728925)

  • 1. Increased incidence of hip fracture in osteoporotic women treated with sodium fluoride.
    Hedlund LR; Gallagher JC
    J Bone Miner Res; 1989 Apr; 4(2):223-5. PubMed ID: 2728925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of hip fractures in osteoporotic women treated with sodium fluoride.
    Riggs BL; Baylink DJ; Kleerekoper M; Lane JM; Melton LJ; Meunier PJ
    J Bone Miner Res; 1987 Apr; 2(2):123-6. PubMed ID: 3455161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous hip fractures in fluoride-treated patients: potential causative factors.
    Gutteridge DH; Price RI; Kent GN; Prince RL; Michell PA
    J Bone Miner Res; 1990 Mar; 5 Suppl 1():S205-15. PubMed ID: 2339631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of intermittent therapy with a slow-release fluoride preparation.
    Pak CY; Sakhaee K; Zerwekh JE
    J Bone Miner Res; 1990 Mar; 5 Suppl 1():S149-55. PubMed ID: 2339625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of osteoporotic hip fractures in Spain.
    Herrera A; Martínez AA; Ferrandez L; Gil E; Moreno A
    Int Orthop; 2006 Feb; 30(1):11-4. PubMed ID: 16328387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy.
    Riggs BL; Seeman E; Hodgson SF; Taves DR; O'Fallon WM
    N Engl J Med; 1982 Feb; 306(8):446-50. PubMed ID: 6276746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epidemiology of hip fracture in Asturias].
    Altadill Arregui A; Gomez Alonso C; Virgós Soriano MJ; Diaz López B; Cannata Andía JB
    Med Clin (Barc); 1995 Sep; 105(8):281-6. PubMed ID: 7475477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of nonrandomized trials with slow-release sodium fluoride with a randomized placebo-controlled trial in postmenopausal osteoporosis.
    Pak CY; Adams-Huet B; Sakhaee K; Bell NH; Licata A; Johnston C; Rubin B; Bonnick S; Piziak V; Graham H; Ballard J; Berger R; Fears W; Breslau N; Rubin C
    J Bone Miner Res; 1996 Feb; 11(2):160-8. PubMed ID: 8822339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for osteoporotic hip fractures in Mexicans.
    Clark P; de la Peña F; Gómez García F; Orozco JA; Tugwell P
    Arch Med Res; 1998; 29(3):253-7. PubMed ID: 9775460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The treatment of osteoporosis.
    Melick RA
    Med J Aust; 1986 Jun; 144(12):645-7. PubMed ID: 3520261
    [No Abstract]   [Full Text] [Related]  

  • 11. Marked secular increase in the incidence rates of osteoporotic hip fractures in women and men in southern Israel.
    Liel Y; Castel H; Alkalay D
    Isr Med Assoc J; 2005 Nov; 7(11):708-11. PubMed ID: 16308993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
    Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E
    Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and costs of osteoporosis-associated hip fractures in Austria.
    Koeck CM; Schwappach DL; Niemann FM; Strassmann TJ; Ebner H; Klaushofer K
    Wien Klin Wochenschr; 2001 May; 113(10):371-7. PubMed ID: 11432126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Missing a therapeutic window of opportunity: an audit of patients attending a tertiary teaching hospital with potentially osteoporotic hip and wrist fractures.
    Smith MD; Ross W; Ahern MJ
    J Rheumatol; 2001 Nov; 28(11):2504-8. PubMed ID: 11708425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Water fluoridation and osteoporotic fracture.
    Hillier S; Inskip H; Coggon D; Cooper C
    Community Dent Health; 1996 Sep; 13 Suppl 2():63-8. PubMed ID: 8897754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Epidemiology of the osteoporotic fracture of the hip in the province of Palencia].
    Arboleya LR; Castro MA; Bartolomé E; Gervás L; Vega R
    Rev Clin Esp; 1997 Sep; 197(9):611-7. PubMed ID: 9411564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supplemental calcium for the prevention of hip fracture: potential health-economic benefits.
    Bendich A; Leader S; Muhuri P
    Clin Ther; 1999 Jun; 21(6):1058-72. PubMed ID: 10440627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiresorption therapy and reduction in fracture susceptibility in the osteoporotic elderly patient: open study.
    Muscoso E; Puglisi N; Mamazza C; Lo Giudice F; Testai M; Abbate S; Santangelo A; Panebianco P; Maugeri D
    Eur Rev Med Pharmacol Sci; 2004; 8(2):97-102. PubMed ID: 15267123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of hip fracture over a 10-year period (1991-2000): reversal of a secular trend.
    Chevalley T; Guilley E; Herrmann FR; Hoffmeyer P; Rapin CH; Rizzoli R
    Bone; 2007 May; 40(5):1284-9. PubMed ID: 17292683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of fracture, cardiovascular event, and breast cancer rates at 3 years in postmenopausal women with osteoporosis.
    Silverman SL; Delmas PD; Kulkarni PM; Stock JL; Wong M; Plouffe L
    J Am Geriatr Soc; 2004 Sep; 52(9):1543-8. PubMed ID: 15341559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.